ES336810A1 - Un metodo para producir una cepa de celulas. - Google Patents
Un metodo para producir una cepa de celulas.Info
- Publication number
- ES336810A1 ES336810A1 ES336810A ES336810A ES336810A1 ES 336810 A1 ES336810 A1 ES 336810A1 ES 336810 A ES336810 A ES 336810A ES 336810 A ES336810 A ES 336810A ES 336810 A1 ES336810 A1 ES 336810A1
- Authority
- ES
- Spain
- Prior art keywords
- feline
- virus
- cells
- embryo
- serial passage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000282324 Felis Species 0.000 title abstract 11
- 241000700605 Viruses Species 0.000 title abstract 10
- 210000001161 mammalian embryo Anatomy 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000004232 Enteritis Diseases 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 230000002458 infectious effect Effects 0.000 abstract 3
- 241000282326 Felis catus Species 0.000 abstract 2
- 206010051497 Rhinotracheitis Diseases 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001280522 Feline picornavirus Species 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 210000001691 amnion Anatomy 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000002257 embryonic structure Anatomy 0.000 abstract 1
- 210000000416 exudates and transudate Anatomy 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000002216 heart Anatomy 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 210000005265 lung cell Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 239000002953 phosphate buffered saline Substances 0.000 abstract 1
- 210000002826 placenta Anatomy 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
- 238000010257 thawing Methods 0.000 abstract 1
- 210000002105 tongue Anatomy 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/819—Viral vaccine for feline species, e.g. cats
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB40225/66A GB1177635A (en) | 1966-02-18 | 1966-02-18 | Cell Stains. |
GB4022566 | 1966-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES336810A1 true ES336810A1 (es) | 1968-01-01 |
Family
ID=26241297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES336810A Expired ES336810A1 (es) | 1966-02-18 | 1967-02-14 | Un metodo para producir una cepa de celulas. |
Country Status (13)
Country | Link |
---|---|
US (1) | US3520972A (en, 2012) |
JP (1) | JPS5341230B1 (en, 2012) |
BE (1) | BE694243A (en, 2012) |
CH (1) | CH504532A (en, 2012) |
CY (1) | CY614A (en, 2012) |
DE (1) | DE1617940C2 (en, 2012) |
DK (1) | DK119472B (en, 2012) |
ES (1) | ES336810A1 (en, 2012) |
FR (1) | FR1570435A (en, 2012) |
GB (1) | GB1177635A (en, 2012) |
IL (1) | IL27418A (en, 2012) |
IT (1) | IT983058B (en, 2012) |
NL (1) | NL6702396A (en, 2012) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1300391A (en) * | 1969-08-22 | 1972-12-20 | Nat Res Dev | Cell lines and virus culture |
US3892627A (en) * | 1973-06-04 | 1975-07-01 | Rohm & Haas | Feline panleukopenia vaccine |
US4086134A (en) * | 1973-09-18 | 1978-04-25 | University Of Glasgow | Method for preparation of vaccine against feline leukemia |
US4287178A (en) * | 1974-03-25 | 1981-09-01 | Pitman-Moore, Inc. | Feline rhinotracheitis vaccine and production and use thereof |
US3944469A (en) * | 1974-11-21 | 1976-03-16 | Pitman-Moore, Inc. | Feline calicivirus vaccine and production thereof |
DE2602478C3 (de) * | 1976-01-23 | 1980-10-09 | Behringwerke Ag, 3550 Marburg | Impfstoff gegen die Panleukopenie der Feliden |
ES486442A0 (es) * | 1978-11-30 | 1980-12-16 | Wellcome Found | Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina. |
ES486441A0 (es) * | 1978-11-30 | 1980-12-16 | Wellcome Found | Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina. |
US4193990A (en) * | 1979-02-16 | 1980-03-18 | Cornell Research Foundation, Inc. | Heterotypic canine parvovirus vaccine |
US5514376A (en) * | 1979-09-04 | 1996-05-07 | Merck & Co., Inc. | Cell culture of hepatitis A virus |
US4303644A (en) * | 1979-10-16 | 1981-12-01 | Norden Laboratories, Inc. | Feline infectious peritonitis virus vaccines |
US4303645A (en) * | 1980-04-18 | 1981-12-01 | Cornell Research Foundation, Inc. | Modified living canine parvovirus vaccine |
FR2520378A1 (fr) * | 1982-01-28 | 1983-07-29 | Vaillant Defresne Laboratoires | Perfectionnements apportes aux procedes de preparations de suspensions de cellules fraiches stabilisees destinees a l'usage pharmaceutique, cosmetique ou alimentaire |
US4699785A (en) * | 1984-09-18 | 1987-10-13 | The Regents Of The University Of California | Cell line producing feline leukemia virus |
US5112756A (en) * | 1986-06-02 | 1992-05-12 | Canadian Patents And Development Limited | Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells |
US11823378B2 (en) * | 2019-12-20 | 2023-11-21 | PAIGE.AI, Inc. | Systems and methods for processing electronic images to detect contamination in specimen preparations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL300960A (en, 2012) * | 1962-11-27 | |||
US3423505A (en) * | 1964-10-31 | 1969-01-21 | Univ Toronto | Rabies vaccine and process for preparation thereof |
US3450598A (en) * | 1965-08-24 | 1969-06-17 | Flow Lab | Method for cell propagation |
FR1484638A (fr) * | 1965-11-17 | 1967-06-16 | Rhone Poulenc Sa | Procédé de culture et d'inactivation d'un nouveau virus |
-
1966
- 1966-02-18 GB GB40225/66A patent/GB1177635A/en not_active Expired
-
1967
- 1967-02-10 IL IL27418A patent/IL27418A/xx unknown
- 1967-02-14 US US615922A patent/US3520972A/en not_active Expired - Lifetime
- 1967-02-14 ES ES336810A patent/ES336810A1/es not_active Expired
- 1967-02-17 JP JP993267A patent/JPS5341230B1/ja active Pending
- 1967-02-17 DK DK87967AA patent/DK119472B/da unknown
- 1967-02-17 BE BE694243D patent/BE694243A/xx not_active IP Right Cessation
- 1967-02-17 NL NL6702396A patent/NL6702396A/xx unknown
- 1967-02-17 IT IT34891/67A patent/IT983058B/it active
- 1967-02-17 FR FR1570435D patent/FR1570435A/fr not_active Expired
- 1967-02-20 CH CH246167A patent/CH504532A/de not_active IP Right Cessation
- 1967-02-20 DE DE1617940A patent/DE1617940C2/de not_active Expired
-
1971
- 1971-10-05 CY CY61471A patent/CY614A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IT983058B (it) | 1974-10-31 |
GB1177635A (en) | 1970-01-14 |
DE1617940A1 (de) | 1970-09-10 |
DE1617940C2 (de) | 1985-05-30 |
DK119472B (da) | 1971-01-11 |
FR1570435A (en, 2012) | 1969-06-13 |
CY614A (en) | 1971-10-05 |
BE694243A (en, 2012) | 1967-08-17 |
NL6702396A (en, 2012) | 1967-08-21 |
US3520972A (en) | 1970-07-21 |
JPS5341230B1 (en, 2012) | 1978-11-01 |
CH504532A (de) | 1971-03-15 |
IL27418A (en) | 1971-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES336810A1 (es) | Un metodo para producir una cepa de celulas. | |
Marchette et al. | Studies on the pathogenesis of dengue infection in monkeys. III. Sequential distribution of virus in primary and heterologous infections | |
CA1073814A (en) | Vaccine and method of using | |
US4086134A (en) | Method for preparation of vaccine against feline leukemia | |
Schidlovsky et al. | Herpesvirus in Marek's disease tumors | |
ES373631A1 (es) | Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. | |
CA1039187A (en) | Feline leukemia vaccines | |
US3214340A (en) | Stabilized viable attenuated measles virus vaccines and their production | |
US4571386A (en) | Feline infectious peritonitis vaccine | |
US4034081A (en) | Vaccines against feline leukemia | |
US4980162A (en) | Live vaccine for contagious diseases of chickens | |
JP2002247979A (ja) | マレック病ワクチンおよびその製造方法 | |
Atherton et al. | Propagation in tissue culture of the virus of infectious laryngotracheitis of fowls. | |
le Q Darcel et al. | Recovery of infectious bovine rhinotracheitis virus following corticosteroid treatment of vaccinated animals | |
Inaba et al. | Propagation in laboratory animals and cell cultures of a virus from cattle with bovine epizootic fever | |
Force et al. | Effect of 5-Iodo-2′-Deoxyuridine on Multiplication of Rous Sarcoma Virus in vitro. | |
US3331736A (en) | Modified laryngotracheitis vaccine | |
RU2121366C1 (ru) | Вакцина против оспы овец | |
US3098011A (en) | Process of producing a vaccine against distemper | |
US3057783A (en) | Infectious bovine rhinotracheitis vaccine and method of preparing it | |
Vainio | Studies on murine hepatitis virus (MHV3) in vitro. | |
US3725542A (en) | Intramuscular vaccination program and vaccine against rhinopneumonitis and process for preparing it | |
Parker et al. | Propagation of rabies virus in tissue culture. | |
RU2138289C1 (ru) | Вирусвакцина против болезни ауески | |
SU144122A1 (ru) | Способ изготовлени гидроокисьалюминиевойформолвакцины дл животных против болезни Ауески |